Document is current
Any future updates will be listed below
-
Authors
Mo, Fei https://orcid.org/0000-0002-8601-2568
Yu, Zhiya
Li, Peng
Oh, Jangsuk
Spolski, Rosanne
Zhao, Liang https://orcid.org/0000-0002-2126-6778
Glassman, Caleb R. https://orcid.org/0000-0002-3342-7989
Yamamoto, Tori N. https://orcid.org/0000-0003-1965-7822
Chen, Yun
Golebiowski, Filip M. https://orcid.org/0000-0002-8011-2162
Hermans, Dalton
Majri-Morrison, Sonia
Picton, Lora K.
Liao, Wei
Ren, Min
Zhuang, Xiaoxuan
Mitra, Suman
Lin, Jian-Xin
Gattinoni, Luca https://orcid.org/0000-0003-2239-3282
Powell, Jonathan D.
Restifo, Nicholas P. https://orcid.org/0000-0003-4229-4580
Garcia, K. Christopher https://orcid.org/0000-0001-9273-0278
Leonard, Warren J. https://orcid.org/0000-0002-5740-7448
- License Information
-
More Information
Article History
Received: 5 October 2019
Accepted: 23 July 2021
First Online: 15 September 2021
Competing interests
: W.J.L. K.C.G. and S.M. are inventors on patents and patent applications that include H9T. L.G. is an inventor on a patent that describes methods for the generation and isolation of stem-cell memory T (T<sub>scm</sub>) cells. L.G. has consulting agreements with Lyell Immunopharma, AstraZeneca, Turnstone Biologics, Xcelcyte and Advaxis Immunotherapies. L.G. is on the scientific advisory board of Poseida Therapeutics and Kiromic, and is a stockholder of Poseida Therapeutics.
